COH.AX · COCHLEAR LIMITED
Australia · RS rating 44 · As of 2026-10-14
| Price | 129.28 AUD |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 49 / 76 / 22 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 29 / 19 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +56.4% |
| Market cap (USD) | $5.8B |